BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21982979)

  • 1. Revisiting nuclear phospholipase C signalling in MDS.
    Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L
    Adv Biol Regul; 2012 Jan; 52(1):2-6. PubMed ID: 21982979
    [No Abstract]   [Full Text] [Related]  

  • 2. Inositide-specific phospholipase C signalling in the nucleus.
    Cocco L; Rhee SG; Gilmour RS; Manzoli FA
    Eur J Histochem; 2000; 44(1):45-50. PubMed ID: 10868292
    [No Abstract]   [Full Text] [Related]  

  • 3. Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.
    Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L
    Adv Enzyme Regul; 2007; 47():2-9. PubMed ID: 17335878
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frontiers of inositide-specific phospholipase C in nuclear signalling.
    Cocco L; Maraldi NM; Manzoli FA
    Eur J Histochem; 2004; 48(1):83-8. PubMed ID: 15145779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoinositides signalling in cancer: focus on PI3K and PLC.
    Raimondi C; Falasca M
    Adv Biol Regul; 2012 Jan; 52(1):166-82. PubMed ID: 22019900
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear lipid signalling.
    Irvine RF
    Nat Rev Mol Cell Biol; 2003 May; 4(5):349-60. PubMed ID: 12728269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.
    Faenza I; Billi AM; Follo MY; Fiume R; Martelli AM; Cocco L; Manzoli L
    Anticancer Res; 2005; 25(3B):2039-41. PubMed ID: 16158942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.
    Mongiorgi S; Follo MY; Clissa C; Giardino R; Fini M; Manzoli L; Ramazzotti G; Fiume R; Finelli C; Cocco L
    Curr Top Microbiol Immunol; 2012; 362():235-45. PubMed ID: 23086421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia.
    Lo Vasco VR; Calabrese G; Manzoli L; Palka G; Spadano A; Morizio E; Guanciali-Franchi P; Fantasia D; Cocco L
    Leukemia; 2004 Jun; 18(6):1122-6. PubMed ID: 15085153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C.
    Poli A; Billi AM; Mongiorgi S; Ratti S; McCubrey JA; Suh PG; Cocco L; Ramazzotti G
    J Cell Physiol; 2016 Aug; 231(8):1645-55. PubMed ID: 26626942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear inositide specific phospholipase C signalling - interactions and activity.
    Faenza I; Fiume R; Piazzi M; Colantoni A; Cocco L
    FEBS J; 2013 Dec; 280(24):6311-21. PubMed ID: 23890371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes.
    Herens C; Ketelslegers O; Tassin F; Hansen S; Bours V
    Leukemia; 2006 Mar; 20(3):521-2; author reply 522-3. PubMed ID: 16424863
    [No Abstract]   [Full Text] [Related]  

  • 15. Inositides and the nucleus: phospholipase Cbeta family localization and signaling activity.
    Cocco L; Martelli AM; Mazzotti G; Barnabei O; Manzoli FA
    Adv Enzyme Regul; 2000; 40():83-95. PubMed ID: 10828347
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipids and signal transduction in the nucleus.
    Dygas A; Barańska J
    Acta Biochim Pol; 2001; 48(2):541-9. PubMed ID: 11732623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear localization and signalling activity of inositol lipids.
    Cocco L; Maraldi NM; Capitani S; Martelli AM; Manzoli FA
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):31-43. PubMed ID: 11729971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear phosphoinositides and their roles in cell biology and disease.
    Martelli AM; Ognibene A; Buontempo F; Fini M; Bressanin D; Goto K; McCubrey JA; Cocco L; Evangelisti C
    Crit Rev Biochem Mol Biol; 2011 Oct; 46(5):436-57. PubMed ID: 21913876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
    Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
    Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
    Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
    Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.